Glycated albumin and glycated haemoglobin levels as a measure of monitoring glycaemic control in diabetic patients attending out-patient clinic at Kenyatta National Hospital: a comparative study

Citation:
T L, C S-K, CF O, G W. "Glycated albumin and glycated haemoglobin levels as a measure of monitoring glycaemic control in diabetic patients attending out-patient clinic at Kenyatta National Hospital: a comparative study." East African Journal of Pathology. 2015;2(1):25-29.

Abstract:

Background: Diabetes mellitus (DM) is a chronic metabolic disease that is characterized by persistent hyperglycemia. Monitoring of glycaemic control ir individuals with DM is currently done by a combination of short term, that is daily monitoring of blood glucose and long term biochemical tests especially glycatec haemoglobin(HbA1c) which is done every 2-4 months. Glycated albumin (GA) is a new test for intermediate glycaemic control. It measures averaged plasma gluCOSE level over two to four weeks. This enables closer monitoring and evaluation ot treatment regimen faster than HbAlc.
Objectives: To compare glycated haemoglobin to glycated albumin levels as a measure of monitoring glycaemic control in diabetic patients.
Design: A prospective comparative study.
Methods: The study was carried out on diabetic patients attending the diabetic clinic
at Kenyatta National Hospital.
Results: A total of 260 patients were enrolled into the study. The mean age was 52 years with a standard deviation of 12.3. There was a female preponderance of 60.4%, Random blood sugar analysis showed that, the population with good glycaemic control constituted 156 (60%). Majority of the patients had good glycaemic control 170 (65.4%) based on the HbAlc assay, compared to 39.4% in GA.There was a good correlation between HbAlc and glycated albumin with R2value of 0.64.
Conclusion: More patients showed good glycaemic control based on HbAlc compared to glycated albumin. There was correlation between .HbAlc and glycated albumin with R2 value of 0.64. There is need to introduce glycated albumin as a method of intermediate glycaemic control in the hospital.

UoN Websites Search